Serge Verreault

Serge Verreault has an extensive work experience that spans over several companies. Serge started their career at Groupe St-Hubert in 1985 as a Server and worked there until 1988. Serge then joined Medicago in 2000 as a Project Manager and stayed until 2001. In 2002, they moved to Valeant Canada Ltd. where they held various positions such as Analyst, Manager, and Director of Business Development until 2011. From 2010 to 2017, they worked at Valeant Pharmaceuticals, assuming roles such as Senior Director, Director of Business Development & General Manager, and Executive Director of Business Development. Finally, they are currently serving as the CEO of Crescita Therapeutics Inc. since April 2018 and has also been the President of the company since April 2017.

Serge Verreault pursued their education starting in the year 1998, when they enrolled at Université Laval. Serge completed their studies in 2001, obtaining a Master of Business Administration (MBA) with a focus on International Marketing. Additionally, in the year 2000, they attended Ecole des hautes Etudes commerciales du Nord, where they also pursued an MBA degree, specializing in International Marketing.